Mechanisms regulating normal and ectopic endochondral ossification
正常和异位软骨内骨化的调节机制
基本信息
- 批准号:9900719
- 负责人:
- 金额:$ 36.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-01 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:ACVR1 geneAblationAccountingActivinsAdultAffectBirthBone Morphogenetic ProteinsBurn injuryCartilageCell FractionationCell Surface ReceptorsCell surfaceCellsChildChondrocytesChondrogenesisComplexDataDrosophila pros proteinElementsEmbryonic DevelopmentEpiphysial cartilageFamily memberFlareFractureFutureGeneticHealthHeterotopic OssificationHypertrophyImmunoprecipitationImplantIn VitroInflammationInflammatoryInjuryLeadLightLimb BudMesenchymalModelingMusMutant Strains MiceMutationOperative Surgical ProceduresOsteogenesisPathogenesisPathogenicityPathologyPharmacologyPhysiologic OssificationProcessProteinsReceptor SignalingRegulationRoleSeveritiesSignal TransductionSiteSkeletonSourceStimulusStructureSurfaceTestingTransforming Growth Factor betaTraumaWild Type MouseWorkactivin Abasebonebone morphogenetic protein receptor type Icartilaginouscrosslinkcytokinehealingin vivoinsightinterestlive cell imaginglong bonemacrophagemast cellmatrigelmembermouse modelmutantnon-geneticnovelprogenitorprogressive myositis ossificansreceptorrecruitrib bone structureskeletalspine bone structurestem cellstargeted treatment
项目摘要
Endochondral ossification is the process by which long bones, ribs, vertebrae and other skeletal
elements form and grow during embryogenesis and after birth. During this process, preskeletal mesenchymal
cells condense and differentiate into cartilaginous anlaga that provide the template and framework of the
future skeleton. Within these incipient structures, the chondrocytes become organized in growth plates,
undergo maturation and hypertrophy, and pave the way for endochondral bone formation. This critical multi-
step process is recapitulated in healing of most bone fractures, but can also be usurped in pathologies such as
heterotopic ossification. HO consists of formation of endochondral bone that forms and accumulates at ectopic
sites and causes many health problems. One form of HO is common and non-genetic and is triggered by
trauma, invasive surgeries and ensuing inflammation. A congenital, severe and often fatal form of HO is
initiated by local flare-ups and is driven by activating mutations in ACVR1 encoding the type I bone
morphogenetic protein (BMP) receptor ALK2. Up until recently, the acquired and congenital forms of HO were
thought to follow the same pathogenic cascade given that they both involve an initial inflammatory stage and a
subsequent endochondral process. However, recent studies by others suggested that congenital HO is caused
by activin A, normally an antagonist of BMP/canonical signaling that in this condition, however, would interact
with mutant ALK2 and elicit pSMAD1/5/8 signaling. If correct, the data would imply that genetic and non-
genetic forms of HO are distinct processes distinguishable by the manner in which they are triggered at cell
level and may require distinct therapies. Because we have long been working on the pathogenesis of genetic
and non-genetic forms of HO and have a vested interest, we carried out preliminary studies to further assess
those recent studies. We found that activin A is actually abundantly expressed in both non-genetic and genetic
HO in mouse models, greatly stimulates chondrogenesis in wild type preskeletal mesenchymal cells, and
promotes HO in wild type mice. These and other data lead to the central premise of this project that both
genetic and non-genetic forms of HO involve, and are promoted by, activin A. The greater severity of genetic
HO would result from greater responsiveness of mutant chondrogenic progenitors to activin A and unruly
mutant ALK2 signaling and action, but both non-genetic and genetic forms of HO would be amenable to an
anti-activin A-based therapy. Our Aims are: (1) To clarify the mechanisms of activin A action in
chondrogenesis; (2) To determine activin A receptor composition and cell surface dynamics; and (3) To
genetically test the roles of activin A in HO and its usefulness as a therapy target. We anticipate this project will
provide novel insights into the pathogenesis of genetic and non-genetic forms of HO and also fundamental
basic insights into the regulation of endochondral ossification. It will also provide a springboard toward an
effective universal therapy for HO in both children and adults.
软骨内骨化是长骨、肋骨、椎骨和其他骨骼
元素在胚胎发生和出生后形成和生长。在此过程中,前间充质
细胞凝聚并分化成软骨原纤维,为细胞的形成提供模板和框架。
未来的骷髅在这些初始结构中,软骨细胞在生长板中变得有组织,
经历成熟和肥大,并为软骨内骨形成铺平道路。这一关键的多-
在大多数骨折的愈合过程中,重复了一个渐进过程,但在病理学中,
异位骨化HO包括软骨内骨的形成,其在异位位置形成并积累,
它会导致许多健康问题。HO的一种形式是常见的和非遗传的,并且由以下因素触发:
创伤、侵入性手术和随之而来的炎症。HO是一种先天性、严重且往往致命的形式,
由局部发作引发,并由编码I型骨的ACVR 1中的激活突变驱动
形态发生蛋白(BMP)受体ALK 2。直到最近,获得性和先天性HO的形式是
认为它们遵循相同的致病级联,因为它们都涉及初始炎症阶段和炎症反应。
随后的软骨内发育过程。然而,其他人最近的研究表明,先天性HO是由
通过激活素A,通常是BMP/经典信号传导的拮抗剂,然而,在这种情况下,
与突变ALK 2结合并引发pSMAD 1/5/8信号传导。如果正确的话,这些数据将意味着遗传和非遗传-
HO的遗传形式是不同的过程,可以通过它们在细胞中被触发的方式来区分。
水平,可能需要不同的治疗。因为我们长期以来一直致力于研究遗传性
和非遗传形式的HO和既得利益,我们进行了初步研究,以进一步评估
这些最近的研究。我们发现,激活素A实际上在非遗传和遗传性肿瘤中都有大量表达,
在小鼠模型中,HO极大地刺激野生型前间充质细胞中的软骨形成,
促进野生型小鼠中的HO。这些和其他数据导致这个项目的中心前提,
HO的遗传和非遗传形式涉及激活素A并由激活素A促进。遗传性疾病的严重程度
HO可能是由于突变的软骨祖细胞对激活素A的反应性更强,
突变的ALK 2信号传导和作用,但HO的非遗传和遗传形式都将服从于突变的ALK 2信号传导和作用。
基于抗激活素A的治疗。我们的目的是:(1)阐明激活素A的作用机制,
软骨形成;(2)确定激活素A受体组成和细胞表面动力学;和(3)
基因测试激活素A在HO中的作用及其作为治疗靶点的有用性。我们预计该项目将
为遗传和非遗传形式的HO的发病机制提供了新的见解,
对软骨内骨化调节的基本认识。它还将提供一个跳板,
在儿童和成人中用于HO的有效通用疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Maurizio Pacifici其他文献
Maurizio Pacifici的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Maurizio Pacifici', 18)}}的其他基金
Regulation of limb synovial joint organization and function
肢体滑膜关节组织和功能的调节
- 批准号:
10508521 - 财政年份:2022
- 资助金额:
$ 36.68万 - 项目类别:
Regulation of limb synovial joint organization and function
肢体滑膜关节组织和功能的调节
- 批准号:
10674028 - 财政年份:2022
- 资助金额:
$ 36.68万 - 项目类别:
2016 Bones & Teeth Gordon Research Conference and Gordon Research Seminar
2016 骨头
- 批准号:
9204947 - 财政年份:2015
- 资助金额:
$ 36.68万 - 项目类别:
2016 Bones & Teeth Gordon Research Conference and Gordon Research Seminar
2016 骨头
- 批准号:
9045147 - 财政年份:2015
- 资助金额:
$ 36.68万 - 项目类别:
Pathogenic Mechanisms in Hereditary Multiple Exostoses Syndrome
遗传性多发性外生骨疣综合征的发病机制
- 批准号:
10442054 - 财政年份:2011
- 资助金额:
$ 36.68万 - 项目类别:
Pathogenic Mechanisms in Hereditary Multiple Exostoses Syndrome
遗传性多发性外生骨疣综合征的发病机制
- 批准号:
10598638 - 财政年份:2011
- 资助金额:
$ 36.68万 - 项目类别:
Pathogenic Mechanisms in Hereditary Multiple Exostoses Syndrome
遗传性多发性外生骨疣综合征的发病机制
- 批准号:
9309201 - 财政年份:2011
- 资助金额:
$ 36.68万 - 项目类别:
相似海外基金
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
- 批准号:
24K11201 - 财政年份:2024
- 资助金额:
$ 36.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 36.68万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
- 批准号:
24K11281 - 财政年份:2024
- 资助金额:
$ 36.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
- 批准号:
2338890 - 财政年份:2024
- 资助金额:
$ 36.68万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334777 - 财政年份:2024
- 资助金额:
$ 36.68万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334775 - 财政年份:2024
- 资助金额:
$ 36.68万 - 项目类别:
Continuing Grant
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
- 批准号:
EP/Z001145/1 - 财政年份:2024
- 资助金额:
$ 36.68万 - 项目类别:
Fellowship
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334776 - 财政年份:2024
- 资助金额:
$ 36.68万 - 项目类别:
Continuing Grant
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
- 批准号:
2320040 - 财政年份:2023
- 资助金额:
$ 36.68万 - 项目类别:
Standard Grant
Collaborative Research: CDS&E: An experimentally validated, interactive, data-enabled scientific computing platform for cardiac tissue ablation characterization and monitoring
合作研究:CDS
- 批准号:
2245152 - 财政年份:2023
- 资助金额:
$ 36.68万 - 项目类别:
Standard Grant